Hot Investor Mandate : Preventative Health Firm Opens Seed Fund to Invest in Reducing Healthcare Costs

5 Mar

A major provider of preventative and diagnostic services in Europe has a $50M seed stage fund through which they invest mainly in Seed to Series A companies across all geographies. The firms are separate entities and as an institutional venture capital firm, financial return is an important factor. However, because of this affiliation, the seend fund is able to leverage corporate benefits to support the growing needs of their portfolio companies. The firm has invested in Europe and the USA. Initial sizes of investment can largely vary, from $250K to 3M and a portion of their fund is reserved for follow-on investment.

Traditionally, the fund has been most interested in healthcare IT and services companies that address important problems in the healthcare industry, including reducing healthcare costs and improving patient outcomes. However, the firm has been pushing beyond healthtech and pursuing investments in the fields of diagnostics, genomics, and medtech. The firm is not interested in biotech.

The fund is able to leverage their relationship with the parent company to provide hands-on support for their portfolio companies. The firm is open to both leading and co-investing and has done both. The firm does not have specific requirements for the company or management team as long as they have compelling technology.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: